Ishkanian AS - Search Results

1

NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy.

Locke JA, Zafarana G, Ishkanian AS, Milosevic M, Thoms J, Have CL, Malloff CA, Lam WL, Squire JA, Pintilie M, Sykes J, Ramnarine VR, Meng A, Ahmed O, Jurisica I, van der Kwast T, Bristow RG. Locke JA, et al. Among authors: ishkanian as. Clin Cancer Res. 2012 Jan 1;18(1):308-16. doi: 10.1158/1078-0432.CCR-11-2147. Epub 2011 Nov 2. Clin Cancer Res. 2012. PMID: 22048240

2

An efficient method for the assessment of DNA quality of archival microdissected specimens.

Siwoski A, Ishkanian A, Garnis C, Zhang L, Rosin M, Lam WL. Siwoski A, et al. Mod Pathol. 2002 Aug;15(8):889-92. doi: 10.1097/01.MP.0000024288.63070.4F. Mod Pathol. 2002. PMID: 12181275

3

Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer.

Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP, Lam WL. Garnis C, et al. Genes Chromosomes Cancer. 2004 Jan;39(1):93-8. doi: 10.1002/gcc.10294. Genes Chromosomes Cancer. 2004. PMID: 14603447

4

Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays.

Watson SK, deLeeuw RJ, Ishkanian AS, Malloff CA, Lam WL. Watson SK, et al. Among authors: ishkanian as. BMC Genomics. 2004 Jan 14;5(1):6. doi: 10.1186/1471-2164-5-6. BMC Genomics. 2004. PMID: 14723794 Free PMC article.

5

A tiling resolution DNA microarray with complete coverage of the human genome.

Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, Coe BP, Snijders A, Albertson DG, Pinkel D, Marra MA, Ling V, MacAulay C, Lam WL. Ishkanian AS, et al. Nat Genet. 2004 Mar;36(3):299-303. doi: 10.1038/ng1307. Epub 2004 Feb 15. Nat Genet. 2004. PMID: 14981516

6

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer.

Ishkanian AS, Mallof CA, Ho J, Meng A, Albert M, Syed A, van der Kwast T, Milosevic M, Yoshimoto M, Squire JA, Lam WL, Bristow RG. Ishkanian AS, et al. Prostate. 2009 Jul 1;69(10):1091-100. doi: 10.1002/pros.20959. Prostate. 2009. PMID: 19350549

7

Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer.

Ishkanian AS, Zafarana G, Thoms J, Bristow RG. Ishkanian AS, et al. Acta Oncol. 2010 Oct;49(7):888-94. doi: 10.3109/0284186X.2010.499371. Acta Oncol. 2010. PMID: 20590366 Review.

8

Upfront observation versus radiation for adult pilocytic astrocytoma.

Ishkanian A, Laperriere NJ, Xu W, Millar BA, Payne D, Mason W, Sahgal A. Ishkanian A, et al. Cancer. 2011 Sep 1;117(17):4070-9. doi: 10.1002/cncr.25988. Epub 2011 Mar 9. Cancer. 2011. PMID: 21391213 Free article.

9

Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy.

Zafarana G, Ishkanian AS, Malloff CA, Locke JA, Sykes J, Thoms J, Lam WL, Squire JA, Yoshimoto M, Ramnarine VR, Meng A, Ahmed O, Jurisica I, Milosevic M, Pintilie M, van der Kwast T, Bristow RG. Zafarana G, et al. Among authors: ishkanian as. Cancer. 2012 Aug 15;118(16):4053-62. doi: 10.1002/cncr.26729. Epub 2012 Jan 26. Cancer. 2012. PMID: 22281794 Free article.

10

Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer.

Milosevic M, Warde P, Ménard C, Chung P, Toi A, Ishkanian A, McLean M, Pintilie M, Sykes J, Gospodarowicz M, Catton C, Hill RP, Bristow R. Milosevic M, et al. Clin Cancer Res. 2012 Apr 1;18(7):2108-14. doi: 10.1158/1078-0432.CCR-11-2711. Epub 2012 Mar 31. Clin Cancer Res. 2012. PMID: 22465832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page